Shashikant Kulkarni

The University of Texas MD Anderson Cancer Center

Also affiliated with Baylor College of Medicine, Baylor Genetics

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes”.

A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1872068

N/A

0DataRank · unranked

8 citations

Michael P. Rettig, Theresa Fletcher, Julie Ritchey, Leah Gehrs, Kyle McFarland +15 more

Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)

Genetics in Medicine(2022)10.1016/j.gim.2022.01.001

N/A

0DataRank · unranked

245 citations

Malachi Griffith, Arpad Danos, Beth A. Pitel, Subha Madhavan, Xue‐Lu Liu +42 more